• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    OncoGenex Pharmaceuticals, Inc. (OGXI)

    -NasdaqCM
    2.20 Up 0.10(4.76%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:2.10
    Open:2.10
    Bid:N/A
    Ask:2.64 x 8000
    1y Target Est:7.71
    Beta:0.75
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:2.10 - 2.29
    52wk Range:1.98 - 14.25
    Volume:573,109
    Avg Vol (3m):198,906
    Market Cap:46.82M
    P/E (ttm):N/A
    EPS (ttm):-1.66
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OGXI

    Comparison

    Symbol% ChgMkt Cap
    OGXIUp 4.76%46.82M
    BMYUp 0.73%98.83B
    CELGUp 3.42%90.53B
    PFEUp 0.73%199.42B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.50
    Quarterly EPS Est (Dec-14) :-0.30
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback